All In Biotech

Drug Trial Radar · NCT07828197

A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 135 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

135

Planned (sponsor's estimate)

Start

Sep 3, 2026

Primary completion

Oct 2026

Study completion Nov 2026

Sponsor

Sponsor type
Industry
First posted
Sep 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the relative bioavailability of a single subcutaneous injection of HDM1005 solution at different injection sites (upper arm and thigh)by using the abdomen subcutaneous injection as a control.

Conditions

  • Overweight and/or Obesity
  • Healthy Participants

Interventions

  • HDM1005Drug

    2.0 mg, SC, single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Up to Day 29
  2. AUC(0-t)Time frame: Up to Day 29
  3. AUC(0-∞)Time frame: Up to Day 29

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.